ASA: Herpes Zoster Vaccine May Reduce Risk for Stroke
WEDNESDAY, Feb. 12, 2020 -- Vaccination with zoster vaccine live (ZVL) is associated with a reduced risk for stroke among older adults, according to a study to be presented at the American Stroke Association International Stroke Conference, held... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - February 12, 2020 Category: Pharmaceuticals Source Type: news

Live Zoster Shot May Be Safe in People With Mild Immunosuppression Live Zoster Shot May Be Safe in People With Mild Immunosuppression
Live attenuated varicella zoster vaccine appears to be safe for individuals with mild immunosuppression, according to new findings.Reuters Health Information (Source: Medscape Allergy Headlines)
Source: Medscape Allergy Headlines - February 11, 2020 Category: Allergy & Immunology Tags: Infectious Diseases News Source Type: news

Risk of herpes zoster after exposure to varicella to explore the exogenous boosting hypothesis: self controlled case series study using UK electronic healthcare data
Study of 9604 adults with both household exposure to varicella and an episode of zoster found that exposure to varicella is linked to reduction in risk of zoster by ~30% over 20 years, though findings cannot be used to justify for or against specific vaccination schedules. (Source: Current Awareness Service for Health (CASH))
Source: Current Awareness Service for Health (CASH) - January 24, 2020 Category: Consumer Health News Source Type: news

Exposure to chickenpox as adult does not fully protect against shingles
Adults re-exposed to the herpes zoster virus found to be around 30% less likely to develop shingles Related items fromOnMedica GPs are dealing with growing flu rates Experts predict 'invigorated' winter flu Illness poorly managed in those with learning disability Flu activity appears to be nearing its peak Doctors can help overcome ‘vaccine hesitancy’ (Source: OnMedica Latest News)
Source: OnMedica Latest News - January 23, 2020 Category: UK Health Source Type: news

Herpes zoster (shingles) immunisation programme 2018 to 2019: evaluation reports
These reports provide an evaluation of the shingles vaccination programme in England from 2018 to 2019. (Source: Current Awareness Service for Health (CASH))
Source: Current Awareness Service for Health (CASH) - January 9, 2020 Category: Consumer Health News Source Type: news

Live Zoster Vaccine Safe in People on TNF Inhibitors Live Zoster Vaccine Safe in People on TNF Inhibitors
Patients with rheumatic diseases who are on tumor-necrosis-factor inhibitor (TNFi) therapy can safely receive the live varicella zoster vaccine, without risking vaccine-related infection, a new study suggests.Reuters Health Information (Source: Medscape Pathology Headlines)
Source: Medscape Pathology Headlines - November 26, 2019 Category: Pathology Tags: Rheumatology News Source Type: news

Herpes zoster vaccine reduces chances of shingles after stem cell transplants
This NIHR Signal says that the risk of shingles is about 10% per year in adults after autologous stem cell transplant. The evidence summary indicates that two doses of deactivated herpes zoster vaccine could be a safe and effective way to reduce that risk by about two thirds.This effect is similar to another, heat-treated, non-live vaccine. Either vaccine could reduce the pain and need for medical treatment associated with shingles, and long-lasting complications such as post-herpetic neuralgia. It's not yet known if people need to continue taking acyclovir as well. (Source: Current Awareness Service for Health (CASH))
Source: Current Awareness Service for Health (CASH) - November 20, 2019 Category: Consumer Health News Source Type: news

New Shingles Vaccine: What You Need to Know New Shingles Vaccine: What You Need to Know
The shingles vaccine Shingrix was approved in 2017. Doctors say they are learning more about how it works, its safety risks, and how it compares to Zostavax.WebMD Health News (Source: Medscape Infectious Diseases Headlines)
Source: Medscape Infectious Diseases Headlines - November 15, 2019 Category: Infectious Diseases Tags: Family Medicine/Primary Care News Source Type: news

Shingrix for Herpes Zoster: A Review Shingrix for Herpes Zoster: A Review
This brief primer reviews the pathophysiology of herpes zoster, and summarizes the results of the clinical trials of Shingrex, the newly approved recombinant vaccine for HZ prevention.Skin Therapy Letter (Source: Medscape Allergy Headlines)
Source: Medscape Allergy Headlines - October 14, 2019 Category: Allergy & Immunology Tags: Dermatology Journal Article Source Type: news

Solid, Hematological Malignancies Show Different Responses to Zoster Vaccines Solid, Hematological Malignancies Show Different Responses to Zoster Vaccines
Inactivated varicella zoster virus (VZV) vaccine elicits protective responses in immunosuppressed patients with solid tumor malignancies, whereas patients with hematological malignancies respond to adjuvanted recombinant zoster vaccine, according to a pair of new studies.Reuters Health Information (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - August 19, 2019 Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news

Can A Vaccine Help Reduce Herpes Zoster After ASCT?
Researchers looked at whether or not a two-dose recombinant zoster vaccine would reduce the incidence of herpes zoster in patients with  hematologic malignancies after autologous stem cell transplantation. (Source: CancerNetwork)
Source: CancerNetwork - July 16, 2019 Category: Cancer & Oncology Authors: Leah Lawrence Source Type: news

Two - Dose Course of Vaccine After HSCT Cuts Incidence of Zoster
Incidence of herpes zoster decreased during median 21 - month follow - up after autologous HSCT (Source: The Doctors Lounge - Oncology)
Source: The Doctors Lounge - Oncology - July 10, 2019 Category: Cancer & Oncology Tags: Infections, Oncology, Pharmacy, Journal, Source Type: news

Two-Dose Course of Vaccine After HSCT Cuts Incidence of Zoster
WEDNESDAY, July 10, 2019 -- A two-dose course of recombinant zoster vaccine is associated with a reduction in the incidence of herpes zoster among adults who have undergone autologous hematopoietic stem cell transplantation (HSCT), according to a... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - July 10, 2019 Category: Pharmaceuticals Source Type: news

Shingrix cost  effective versus Zostavax in Canada
(Source: PharmacoEconomics and Outcomes News)
Source: PharmacoEconomics and Outcomes News - July 1, 2019 Category: Drugs & Pharmacology Source Type: news

2003 to 2014 Saw Incidence of Herpes Zoster Drop in Children
MONDAY, June 10, 2019 -- From 2003 to 2014, there was a decrease in herpes zoster (HZ) incidence among children, with lower incidence rates for varicella-vaccinated versus unvaccinated children, according to a study published online June 10 in... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - June 10, 2019 Category: Pharmaceuticals Source Type: news

Mayo Clinic Minute: What are eye shingles?
Shingles is caused by the varicella-zoster virus -- the same virus that causes chickenpox. If you've had chickenpox, the virus can lie dormant in your body's nerve tissue for years when suddenly it's triggered by stress or a weakened immune system, and manifests as shingles. A new shingles vaccine called Shingrix is recommended for anyone [...] (Source: News from Mayo Clinic)
Source: News from Mayo Clinic - April 15, 2019 Category: Databases & Libraries Source Type: news

Zostavax (Zoster Vaccine Live) - updated on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - March 18, 2019 Category: Drugs & Pharmacology Source Type: news

Shingles Vaccine (Zoster Shingles Vaccine Live, Zostavax)
Title: Shingles Vaccine (Zoster Shingles Vaccine Live, Zostavax)Category: MedicationsCreated: 11/9/2010 12:00:00 AMLast Editorial Review: 3/13/2019 12:00:00 AM (Source: MedicineNet Skin General)
Source: MedicineNet Skin General - March 13, 2019 Category: Dermatology Source Type: news

Postlicensure Safety Surveillance of Shingrix Postlicensure Safety Surveillance of Shingrix
Are early safety monitoring findings for recombinant zoster vaccine (Shingrix) consistent with prelicensure clinical trial data?Morbidity & Mortality Weekly Report (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - February 22, 2019 Category: Consumer Health News Tags: Public Health & Prevention Journal Article Source Type: news

Recombinant Zoster Vaccine Cost-Effective in Simulation
TUESDAY, Feb. 19, 2019 -- Vaccination with recombinant zoster vaccine (RZV) seems cost-effective under a wide range of conditions, according to a study published online Feb. 19 in the Annals of Internal Medicine. Lisa A. Prosser, Ph.D., from the... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - February 19, 2019 Category: Pharmaceuticals Source Type: news

CDC Examines Safety of Recombinant Zoster Vaccine
MONDAY, Feb. 4, 2019 -- During the first eight months of recombinant zoster vaccine (RZV) use, there were reports of 4,381 adverse events, 3 percent of which were serious, according to research published in the Feb. 1 issue of the U.S. Centers for... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - February 4, 2019 Category: Pharmaceuticals Source Type: news

Post-Onset Shingles Rx Fails to Cut Ischemic Stroke Risk Post-Onset Shingles Rx Fails to Cut Ischemic Stroke Risk
The higher risk for stroke with herpes zoster was not attenuated by antivirals or Zostavax vaccination in older patients, but that shouldn't slow vaccination rates or further study.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - February 1, 2019 Category: Consumer Health News Tags: Cardiology News Source Type: news

Update: Common Shingrix Reactions--Which Can Be Prevented? Update: Common Shingrix Reactions--Which Can Be Prevented?
If administered incorrectly, Shingrix can produce some painful local reactions. Make sure your staff knows the differences between the two herpes zoster vaccines.CDC Expert Commentary (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - February 1, 2019 Category: Consumer Health News Tags: Infectious Diseases Commentary Source Type: news

Early Surveillance Data Confirm Safety of Shingrix Vaccine Early Surveillance Data Confirm Safety of Shingrix Vaccine
New research from the CDC confirms the safety of the Shingrix recombinant zoster vaccine.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - January 31, 2019 Category: Consumer Health News Tags: Infectious Diseases News Source Type: news

Postlicensure Safety Surveillance of Recombinant Zoster Vaccine (Shingrix) - United States, October 2017-June 2018
Early recombinant zoster vaccine safety monitoring findings are consistent with prelicensure clinical trial data. Serious adverse events were rare, and no unexpected patterns were detected. (Source: CDC Morbidity and Mortality Weekly Report)
Source: CDC Morbidity and Mortality Weekly Report - January 31, 2019 Category: American Health Tags: MMWR Morbidity & Mortality Weekly Report Shingles (Herpes Zoster) Shingles Vaccination Vaccine Safety Source Type: news

Herpes zoster infection
This review covers who is at risk, typical presentation, complications, infectiousness, when to prescribe antivirals and which antiviral, when to refer, use of analgesia, latest vaccine recommendations and the difference between Zostavax and Shingrix. (Source: Current Awareness Service for Health (CASH))
Source: Current Awareness Service for Health (CASH) - January 16, 2019 Category: Consumer Health News Source Type: news

Changing Epidemiology of Herpes Zoster After Vaccine Adoption in the U.S. Changing Epidemiology of Herpes Zoster After Vaccine Adoption in the U.S.
Shingles is becoming less common in both adults and children in the U.S., according to results from a database study.Reuters Health Information (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - December 26, 2018 Category: Consumer Health News Tags: Infectious Diseases News Source Type: news

Higher Risk of Shingles Seen in Patients With Certain Cancers
(MedPage Today) -- Vaccine development may help with prevention of herpes zoster in this population (Source: MedPage Today Hematology/Oncology)
Source: MedPage Today Hematology/Oncology - December 14, 2018 Category: Hematology Source Type: news

Herpes zoster (shingles) immunisation programme 2017 to 2018: evaluation report
This report evaluates the fifth year of the shingles vaccination programme in England from 2017 to 2018. (Source: Current Awareness Service for Health (CASH))
Source: Current Awareness Service for Health (CASH) - November 30, 2018 Category: Consumer Health News Source Type: news

Herpes Zoster Recombinant Vaccine Seems Most Effective
THURSDAY, Nov. 8, 2018 -- The herpes zoster adjuvant recombinant subunit vaccine may be more effective than the live attenuated vaccine, though it is associated with an increased risk for adverse events at the injection site, according to a review... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - November 8, 2018 Category: Pharmaceuticals Source Type: news

Pork gelatine in vaccines 'puts many off using them', vegetarians say
Gelatine is added as a stabiliser to prevent vaccines degrading in transportation. In the UK, the worst offenders are the nasal flu vaccine Fluenz Tetra, the shingles jab Zostavax and the MMR. (Source: the Mail online | Health)
Source: the Mail online | Health - October 26, 2018 Category: Consumer Health News Source Type: news

Study: Newer shingles vaccine far more effective
The newer shingles vaccine Shingrix was far more successful in preventing the condition compared with the older vaccine Zostavax among patients 50 and older. (Source: Health News - UPI.com)
Source: Health News - UPI.com - October 26, 2018 Category: Consumer Health News Source Type: news

Systematic review of clinical studies suggests newer shingles vaccine far more effective
(St. Michael's Hospital) A systematic review of clinical studies involving more than two million patients aged 50 years and older suggests the newer shingles vaccine Shingrix was far more successful in preventing the painful condition compared to the older vaccine Zostavax. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - October 25, 2018 Category: International Medicine & Public Health Source Type: news

NATIONAL IMMUNIZATION ALERT: Zoster Shingles vaccines and non-seasonal flu vaccines are NOT COVERED by the Vaccine Injury Compensation Program
(Natural News) In the 1980s, after a series of very serious lawsuits against vaccine companies from healthcare providers due to vaccine injuries, the CDC, in cahoots with vaccine manufacturers, created the Vaccine Injury Compensation Program (VICP) so that no vaccine maker could ever be sued again. From that date forward, if any U.S. person was... (Source: NaturalNews.com)
Source: NaturalNews.com - October 23, 2018 Category: Consumer Health News Source Type: news

Colorado parents are holding 'chickenpox parties' to infect their kids
The group in Boulder, part of a growing anti-vaxxer movement, believe infecting their kids is safer than getting a varicella zoster vaccine, and they wrongly claim it's advice from the NHS and CDC. (Source: the Mail online | Health)
Source: the Mail online | Health - October 19, 2018 Category: Consumer Health News Source Type: news

Consumer Health: Shingles -- if you're over 50, get your vaccination
Shingles: Vaccination can lower your risk? Shingles is a viral infection caused by the varicella-zoster virus ? the same virus that causes chickenpox. After you've had chickenpox, the virus remains inactive in nerve tissue near your spinal cord and brain. Years later, the virus may reactivate as shingles, causing a painful skin rash along nerve [...] (Source: News from Mayo Clinic)
Source: News from Mayo Clinic - September 28, 2018 Category: Databases & Libraries Source Type: news

Shingles vaccine responsible for causing huge number of shingles cases, vaccine injuries
(Natural News) Zostavax, a popular shingles vaccine, is in hot water: The inoculation has been tied to numerous cases of vaccine injury, and even shingles itself. Merck, the company that makes Zostavax, is now facing multiple lawsuits from patients and families harmed by their product. At least 80 deaths tied to the Zostavax vaccine have been... (Source: NaturalNews.com)
Source: NaturalNews.com - August 28, 2018 Category: Consumer Health News Source Type: news

Shingrix Vaccine Makes Shingles Less Severe, Disruptive to Quality of Life Shingrix Vaccine Makes Shingles Less Severe, Disruptive to Quality of Life
The recombinant zoster vaccine Shingrix prevents shingles, and if people do contract the virus, it reduces the severity of illness, two company-funded studies suggest.Reuters Health Information (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - July 30, 2018 Category: Consumer Health News Tags: Medscape Today News Source Type: news

Shingrix (Zoster Vaccine Recombinant, Adjuvanted Suspension for Intramuscular Injection) - updated on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - July 27, 2018 Category: Drugs & Pharmacology Source Type: news

Most Eligible IBD Patients Don't Get Shingles Vaccine Most Eligible IBD Patients Don't Get Shingles Vaccine
Just one in five patients with inflammatory bowel disease (IBD) who are eligible for the herpes zoster (HZ) vaccine actually receive it, according to new study in VA patients.Reuters Health Information (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - July 24, 2018 Category: Consumer Health News Tags: Medscape Today News Source Type: news

Age Threshold of 50 for New Zoster Vaccine Not Cost-Effective: Study Age Threshold of 50 for New Zoster Vaccine Not Cost-Effective: Study
The new Advisory Committee on Immunization Practices (ACIP) guideline that recommends the new recombinant adjuvanted zoster subunit vaccine (RZV) over the live attenuated zoster vaccine (ZVL) and lowers the vaccination age to 50 years is not cost-effective, according to a new analysis.Reuters Health Information (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - July 17, 2018 Category: Consumer Health News Tags: Medscape Today News Source Type: news

What is the Interval For Non-simultaneous Administration of Live Virus Vaccines?
Discussion Vaccines are a mainstay of infectious disease prevention and health promotion. Infants, children and adults benefit from vaccines the most when they are given on the recommended schedules. However there are times when this is not possible as children come to the physician a little early, or a little late, or had unavailable records and so received addition vaccine, etc. There are many questions that arise because of these timing issues such as the one above. Standard vaccine schedules can be reviewed here. Commonly administered vaccines includes: Live-attenuated vaccines Cholera Measles, mumps, rubella (MMR ...
Source: PediatricEducation.org - July 9, 2018 Category: Pediatrics Authors: pediatriceducationmin Tags: Uncategorized Source Type: news

Adjuvanted recombinant zoster vaccine cost effective in US?
(Source: PharmacoEconomics and Outcomes News)
Source: PharmacoEconomics and Outcomes News - July 1, 2018 Category: Drugs & Pharmacology Source Type: news

Vaccine Administration Errors Involving Zoster Vaccine Vaccine Administration Errors Involving Zoster Vaccine
This report indicates that some vaccine providers remain confused.Morbidity & Mortality Weekly Report (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - June 15, 2018 Category: Consumer Health News Tags: Infectious Diseases Journal Article Source Type: news

Notes from the Field: Vaccine Administration Errors Involving Recombinant Zoster Vaccine — United States, 2017–2018
(Source: CDC Morbidity and Mortality Weekly Report)
Source: CDC Morbidity and Mortality Weekly Report - May 24, 2018 Category: American Health Source Type: news

Robust Immune Responses for Herpes Zoster Subunit Vaccine
MONDAY, May 21, 2018 -- Recipients of the herpes zoster subunit vaccine (HZ/su), consisting of varicella-zoster virus glycoprotein E (gE) and AS01B Adjuvant System, develop robust immune responses, according to a study published in the June 1 issue... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - May 21, 2018 Category: Pharmaceuticals Source Type: news

Infectious Diseases A-Z: Over age 50? Get your shingles vaccine
All adults over 50 are encouraged to get the new shingles vaccine, Shingrix. The Centers for Disease Control and Prevention recommends Shingrix for the prevention of herpes zoster (shingles) and related complications. "When people get shingles, it?s a very painful ordeal," says Dr. Pritish Tosh, an infectious diseases specialist at Mayo Clinic. Watch: Dr. Pritish [...] (Source: News from Mayo Clinic)
Source: News from Mayo Clinic - May 7, 2018 Category: Databases & Libraries Source Type: news

Recommendations for the Use of Herpes Zoster Vaccines
May 10, 2018 2:00-3:00pm ET. (Source: PHPartners.org)
Source: PHPartners.org - May 4, 2018 Category: International Medicine & Public Health Source Type: news

Shingles: guidance and vaccination programme
This Guidance Collection covering the characteristics, management and surveillance of shingles (herpes zoster) was updated in April 2018. (Source: Current Awareness Service for Health (CASH))
Source: Current Awareness Service for Health (CASH) - May 2, 2018 Category: Consumer Health News Source Type: news

Zoster Vaccination Pearls
Rx Shorts: With 2 shingles vaccines available, questions continue to multiply. Take away 4 small pearls to help answer patient questions and yours. (Source: ConsultantLive)
Source: ConsultantLive - May 2, 2018 Category: Internal Medicine Authors: Matthew Baker, PharmD Tags: Immunization Infectious Disease Vaccines Source Type: news